This book is divided into five sections and ten chapters, highlighting recent advances in and #60;i and #62;Aspergillus and #60;/i and #62; and aspergillosis from pathogenicity to novel diagnosis based on biosensors and metagenomic next-generation sequencing, mechanisms of antifungal drug resistance, and #60;i and #62;Aspergillus and #60;/i and #62;–human interactions, immunopathogenesis of invasive aspergillosis, post-viral aspergillosis, treatment strategies, and the importance of beneficial and harmful metabolites of and #60;i and #62;Aspergillus and #60;/i and #62;in public health and industry. This book presents cutting-edge research on and #60;i and #62;Aspergillus and #60;/i and #62; along with useful information for mycologists, microbiologists, toxicologists, plant pathologists, and pharmacologists who may be interested in understanding the impact, significance, and recent advances within the genus and #60;i and #62;Aspergillus and #60;/i and #62; that have not been critically noticed elsewhere.